Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Vickers-Smith

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
The American Journal of Drug and Alcohol Abuse|October 29, 2025
Racial and ethnic disparities in buprenorphine retention and treatment outcome in a longitudinal cohort of U.S. veterans with opioid use disorderRachel Vickers-Smith, Richard C Crist, Rachel L Kember, et al.
Pharmaceuticals (Basel, Switzerland)|June 24, 2022
Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS)Stefania Chiappini, Rachel Vickers-Smith, Amira Guirguis, et al.
Drug and Alcohol Dependence|November 17, 2019
Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting systemRachel Vickers-Smith, Jiangwen Sun, Richard J Charnigo, et al.
Substance Use & Addiction Journal|June 29, 2026
Decreased Gabapentin Prescription Fills Among Medicaid Enrollees Following State-Level Schedule V Controlled Substance Classification in Kentucky and West VirginiaKatherine Gora Combs, Stephen W Marshall, Rachel Vickers-Smith, et al.
Expert Opinion on Pharmacotherapy|October 19, 2023
Exploring the nexus of binge eating disorder (BED), New Psychoactive Substances (NPS), and misuse of pharmaceuticals: charting a path forwardStefania Chiappini, G Duccio Papanti Pelletier, Rachel Vickers-Smith, et al.
Research Square|September 2, 2025
Multi-ancestry Genome-wide Association Study of Inpatient Opioid Dosing Following Knee or Hip ArthroplastyZeal Jinwala, Christal N Davis, Jackson F SooHoo, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Multi-ancestry Genome-wide Association Study of Inpatient Opioid Dosing Following Knee or Hip ArthroplastyZeal Jinwala, Christal N Davis, Jackson F SooHoo, et al.
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|December 15, 2017
A qualitative analysis of gabapentin misuse and diversion among people who use drugs in Appalachian KentuckyRachel Vickers Smith, Elaine M Boland, April M Young, et al.
Journal of Neurosurgery. Pediatrics|February 15, 2020
Protocol-driven prevention of perioperative hypothermia in the pediatric neurosurgical populationIan Mutchnick, Meena Thatikunta, Julianne Braun, et al.
Drug and Alcohol Dependence|May 19, 2026
Impact of schedule V controlled substance classification of gabapentin on adult gabapentin-involved overdose rates, West Virginia, 2016-2019: A controlled time series analysisKatherine Gora Combs, Juan M Hincapie-Castillo, Nabarun Dasgupta, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
The American Journal of Drug and Alcohol Abuse|October 29, 2025
Racial and ethnic disparities in buprenorphine retention and treatment outcome in a longitudinal cohort of U.S. veterans with opioid use disorderRachel Vickers-Smith, Richard C Crist, Rachel L Kember, et al.
Pharmaceuticals (Basel, Switzerland)|June 24, 2022
Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS)Stefania Chiappini, Rachel Vickers-Smith, Amira Guirguis, et al.
Drug and Alcohol Dependence|November 17, 2019
Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting systemRachel Vickers-Smith, Jiangwen Sun, Richard J Charnigo, et al.
Substance Use & Addiction Journal|June 29, 2026
Decreased Gabapentin Prescription Fills Among Medicaid Enrollees Following State-Level Schedule V Controlled Substance Classification in Kentucky and West VirginiaKatherine Gora Combs, Stephen W Marshall, Rachel Vickers-Smith, et al.
Expert Opinion on Pharmacotherapy|October 19, 2023
Exploring the nexus of binge eating disorder (BED), New Psychoactive Substances (NPS), and misuse of pharmaceuticals: charting a path forwardStefania Chiappini, G Duccio Papanti Pelletier, Rachel Vickers-Smith, et al.
Research Square|September 2, 2025
Multi-ancestry Genome-wide Association Study of Inpatient Opioid Dosing Following Knee or Hip ArthroplastyZeal Jinwala, Christal N Davis, Jackson F SooHoo, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Multi-ancestry Genome-wide Association Study of Inpatient Opioid Dosing Following Knee or Hip ArthroplastyZeal Jinwala, Christal N Davis, Jackson F SooHoo, et al.
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|December 15, 2017
A qualitative analysis of gabapentin misuse and diversion among people who use drugs in Appalachian KentuckyRachel Vickers Smith, Elaine M Boland, April M Young, et al.
Journal of Neurosurgery. Pediatrics|February 15, 2020
Protocol-driven prevention of perioperative hypothermia in the pediatric neurosurgical populationIan Mutchnick, Meena Thatikunta, Julianne Braun, et al.
Drug and Alcohol Dependence|May 19, 2026
Impact of schedule V controlled substance classification of gabapentin on adult gabapentin-involved overdose rates, West Virginia, 2016-2019: A controlled time series analysisKatherine Gora Combs, Juan M Hincapie-Castillo, Nabarun Dasgupta, et al.
Pageof 6